Recent advances: Diabetes

British Medical Journal

Volumn 316, Issue 7139, 1998, Pages 1221-1225

  Mandrup Poulsen, Thomas ^a  

^a STENO DIABETES CENTER   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN; METFORMIN; ORAL ANTIDIABETIC AGENT; SULFONYLUREA;

CARDIOVASCULAR RISK; CELL DAMAGE; ENVIRONMENTAL FACTOR; HEALTH CARE COST; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RELEASE; LIFE EXPECTANCY; METABOLIC REGULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NUTRITION; ONSET AGE; ORAL DRUG ADMINISTRATION; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; SHORT SURVEY; VIRUS INFECTION; GENETICS; REVIEW; RISK FACTOR;

DIABETES MELLITUS, TYPE 1; DIABETES MELLITUS, TYPE 2; GLUCOSE; HUMANS; RISK FACTORS;

EID: 0032542846     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (42)

1. Green A, Borch-Johnsen K, Andersen PK, Hougaard P, Keiding N, Kreiner N, et al. Relative mortality of type 1 (insulin-dependent) diabetes in Denmark: 1933-1981. Diabetologia 1985;28:339-42.
2. Joner G, Patrick S. The mortality of children with type 1 (insulin-dependent) diabetes mellitus in Norway, 1973-1988. Diabetologia 1991;34:29-32.
3. Portuese E, Orchard T. Mortality in insulin-dependent diabetes. In: National Diabetes Data Group, ed. Diabetes in America. Bethesda, MD: National Institutes of Health, 1995:221-32. (NIH publication No 95-1468.)
4. Geiss LS, Herman WH, Smith PJ. Mortality in non-insulin-dependent diabetes. In: National Diabetes Data Group, ed. Diabetes in America. Bethesda, MD: National Institutes of Health, 1995:233-55. (NIH publication No 95-1468.)
5. Javitt JC, Chiang Y. Economic impact of diabetes. In: National Diabetes Data Group, ed. Diabetes in America. Bethesda, MD: National Institutes of Health, 1995:605-11. (NIH publication No 95-1468.)
6. McCarty D, Zimmet P. Diabetes 1994 to 2010: global estimates and projections. Leverkusen: Bayes AG, 1994:1-46.
7. Mandrup-Poulsen T. The role of interleukin-1 in the pathogenesis of IDDM. Diabetologia 1996;39:1005-29.
8. Melbak AG, Marner B, Borch-Johnsen K, Nerup J. Incidence of insulin-dependent diabetes mellitus in age groups over 30 years in Denmark. Diabetic Med 1994;11:650-65.
9. Karvonen M, Tuomilehto J, Libman I, LaForte R. A review of the recent epidemiological data on the worldwide incidence of type 1 (insulin-dependent) diabetes mellitus. Diabetologia 1993;36:883-92.
10. Tuomilehto J, Virtala E, Karvonen M. Increase in incidence of insulin-dependent diabetes mellitus among children in Finland. Int J Epidemiol 1995;24:984-92.
11. Gardner SG, Bingley PJ, Sawtell PA, Weeks S, Gale EAM, the Bart's-Oxford Study Group. Rising incidence of insulin dependent diabetes in children aged under 5 years in the Oxford region: time trend analysis. BMJ 1997;315:713-7.
12. Dahlquist G, Ivarsson S, Lindberg B, Forsgren M. Maternal enteroviral infection during pregnancy as a risk factor for childhood IDDM: a population-based case-control study. Diabetes 1995;44:408-13.
13. Tian J, Lehmann PV, Kaufmann DL. T cell cross-reactivity between Coxsackie virus and glutamate decarboxylase is associated with a murine diabetes susceptibility allele. J Exp Med 1994;180:1979-84.
14. Gerstein H. Cow's milk exposure and type 1 diabetes. Diabetes Care 1994;17:13-9.
15. Pietropaolo M, Castano L, Babu S, Buelow R, Kuo YLS, Martin S, et al. Islet cell autoantigen 69-kD (ICA69): molecular cloning characterization of a novel diabetes-associated autoantigen. J Clin Invest 1993;92: 359-71.
16. Petersen JS, Karlsen AE, Markholst H, Wolsaae H, Dyrberg I, Michelsen B. Neonatal tolerization with glutamic acid decarboxylase but not with bovine serum albumin delays the onset of diabetes in NOD mite. Diabetes 1994;43:1478-84.
17. Vaarala O, Paronen J, Otonkoski T, Akerblom HK. Cow milk feeding induces antibodies to insulin in children - a link between cow milk and insulin-dependent diabetes mellitus? Scand J Immunol 1998;47:131-5.
18. Dahlquist G, Bennich SS, Källén B. Intrauterine growth pattern and risk of childhood onset insulin dependent (type 1): population based case-control study. BMJ 1996;313:1174-7.
19. Pinkney JH, Bingley PJ, Sawtell PA, Dunger DB, Gale EAM. Presentation and progress of childhood diabetes mellitus: a prospective population-based study. Diabetologia 1994;37:70-4.
20. Mortensen HB, Hougaard P. Comparison of metabolic control in a cross-sectional study of 2,873 children and adolescents with IDDM from 18 countries. Diabetes Care 1997;20:714-20.
21. Hales CN, Barker DJP. Type 2 (non-insulin dependent) diabetes mellitus: the thrifty phenotype hypothesis. Diabetologia 1992;35:595-601.
22. Cook JTE, Levy JC, Page RCL, Shaw AG, Hattersley AT, Turner RC. Association of low birth weight with beta cell function in the adult first degree relatives of non-insulin dependent diabetic subjects. BMJ 1993;306:302-6.
23. Poulsen P, Vaag AA, Kyvik KO, Møller Jensen D, Beck-Nielsen H. Low birth weight is associated with NIDDM in discordant monozygotic and s dizygotick twin pairs. Diabetologia 1997;10:439-46.
24. Leon DA, Koupilova I, Lithell HO, Berglund L, Mohsen R, Vägerö D, et al. Failure to realise growth potential in utero and adult obesity in relation to blood pressure in 50 year old Swedish men. BMJ 1996;312:401-6.
25. Davies JL, Kawaguchi Y, Bennett ST, Coperman JB, Cordell HJ, Pritchard LE, et al. A genome-wide search for human type I diabetes susceptibility genes. Nature 1994;371:130-6.
26. Owerbach D, Gabbay KH. The search for IDDM susceptibility genes. Diabetes 1996;45:544-51.
27. Ghosh S, Schork NJ. Genetic analysis of NIDDM. Diabetes 1996;45:1-14.
28. Yamagata K, Furuta H, Oda N, Kaisaki PJ, Menzel S, Cox NJ, et al. Mutations in the hepatocyte nuclear factor-4alfa gene in maturity-onset diabetes of the young (MODY1). Nature 1996;384:458-60.
29. Vionnet N, Stolfel M, Takeda J, Yasuda K, Bell G, Zouali M, et al. Nonsense mutation in the glucokinase gene causes early-onset non-insulin-dependent diabetes mellitus. Nature 1992;356:721-2.
30. Yamagata K, Oda N, Kaisaki PJ, Menzel S, Furuta H, Vaxillaire M, et al. Mutations in the hepatocyte nuclear factor-1alfa gene in maturity-onset diabetes of the young (MODY3). Nature 1996;384:455-8.
31. Hansen T, Eiberg H, Rouard M, Vaxillaire M, Möller AM, Rasmussen SK, et al. Novel MODY3 mutations in the hepatocyte nuclear factor-1alfa gene. Diabetes 1997;46:726-30.
32. Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993;329:977-86.
33. Diabete Control and Complications Trial Research Group. The relationship of glycemic exposure (HbAlc) to the risk of development and progression of retinopathy in the diabetes control and complications trial. Diabetes 1995;44:968-83.
34. Diabetes Control and Complications Trial Research Group. The absence of a glycemic threshold for the development of long-term complications: the perspective of the diabetes control and complications trial. Diabetes 1996;45:1289-98.
35. Diabetes Control and Complications Trial Research Group. Hypoglycemia in the diabetes control and complications trial. Diabetes 1997;46:271-86.
36. Diabetes Control and Complications Trial Research Group. Effect of intensive diabetes therapy on neuropsychological function on adults in the diabetes control and complications trial. Ann Intern Med 1996;124:379-88.
37. Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, Motoyoshi S, et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 1995;28:103-17.
38. United Kingdom Prospective Diabetes Study Group. United Kingdom prospective diabetes study (UKPDS) 13: relative efficacy of randomly allocated diet, sulphonylurea, insulin, or metformin in patients with newly diagnosed non-insulin dependent diabetes followed for three years. BMJ 1995;310:83-8.
39. Defronzo RA, Goodman AM, Multicenter Metformin Study Group. Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. N Engl J Med 1995;333:541-9.
40. Yki-Järvinen H, Nikkilä K, Ryysy L, Tulokas T, Vanamo R, Heikkila M. Comparison of bedtime insulin regimens in NIDDM: metformin prevents insulin-induced weight gain [abstract]. Diabetologia 1996; 39:A33.
41. Bloomgarden ZT. American Diabetes Association scientific sessions. 1995. Non-insulin-dependent diabetes mellitus. Diabetes Care 1995;18: 1215-9.
42. Ravid M, Savin H, Jutrin I, Bental T, Katz B, Lishner M. Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients. Ann Intern Med 1993;118:577-81.